As of November 6, 2026, 4 holders' latest Schedule 13D or 13G filings report owning 5% or more of Catheter Precision, Inc. The largest reported stake is C/M Capital Partners, LP's, at 9.99%. 7 filings are on record since August 14, 2025 (Schedule 13G, August 21, 2026).
Who owns Catheter Precision, Inc.?
Sell to companies like Catheter Precision, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: C/M Capital Master Fund, LP · Sole voting: 0 · Shared voting: 878,451 · Sole dispositive: 0 · Shared dispositive: 878,451 · SCHEDULE 13G, 2026-08-21
- · Holder: Seg Jets Spv I, LLC · Percent: 9.79% · Shares: 1,065,620 · SCHEDULE 13G
- · Holder: C/M Capital Master Fund, LP · Percent: 0% · SCHEDULE 13G/A
- · Holder: Jonathan Juchno · Percent: 9.6% · SCHEDULE 13G
- · Holder: Joseph Reda · Percent: 7.5% · SCHEDULE 13G
Catheter Precision, Inc. has 7 Schedule 13D or 13G filings on record since 2025-08-14. 4 holders' latest filing reports 5% or more of common stock, par value $0.0001 per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| C/M Capital Partners, LP | 9.99% | 1,597,328 | SCHEDULE 13G, 2026-08-21 | 2026-08-16 |
| Seg Jets Spv I, LLC | 9.79% | 1,065,620 | SCHEDULE 13G, 2026-07-20 | 2026-07-20 |
| 7.5% | 176,674 | SCHEDULE 13G, 2026-02-11 | 2026-02-06 | |
| 7.5% | 176,674 | SCHEDULE 13G, 2026-02-11 | 2026-02-06 | |
| Armistice Capital, LLC | 4.99% | 1,120,635 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
Holding shares or following this stake? See who's behind Catheter Precision, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Catheter Precision, Inc. and the records around it.
Catheter Precision, Inc. elsewhere on the record
Companies that share a holder
- Joseph Reda also filed stake reports on 3 other companies: 22nd Century Group, Inc. (Aug 2026), Datavault AI Inc. (Feb 2026)
- Gregory Castaldo also filed stake reports on 4 other companies: 22nd Century Group, Inc. (Feb 2026), Datacentrex, Inc. (Feb 2026), Datavault AI Inc. (Feb 2026)
- C/M Capital Master Fund, LP also filed stake reports on 8 other companies: Endovia Health Sciences, Inc. (Oct 2026), Volato Group, Inc. (Jul 2026), Beeline Holdings, Inc. (Jun 2026)
Watch Catheter Precision, Inc.
Get an email when Catheter Precision, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Catheter Precision, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Catheter Precision, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Catheter Precision, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| C/M Capital Master Fund, LP | 0 | 878,451 | 0 | 878,451 | SCHEDULE 13G, 2026-08-21 |
| WVP Emerging Manager Onshore Fund LLC | 0 | 878,451 | 0 | 878,451 | SCHEDULE 13G, 2026-08-21 |
| C/M Capital Partners, LP | 0 | 1,597,328 | 0 | 1,597,328 | SCHEDULE 13G, 2026-08-21 |
| Thomas Walsh | 0 | 1,597,328 | 0 | 1,597,328 | SCHEDULE 13G, 2026-08-21 |
| Jonathan Juchno | 0 | 1,597,328 | 0 | 1,597,328 | SCHEDULE 13G, 2026-08-21 |
| Seg Jets Spv I, LLC | 0 | 1,065,620 | 0 | 1,065,620 | SCHEDULE 13G, 2026-07-20 |
The latest filing identifies Catheter Precision, Inc. by CUSIP 74933X708 and gives its principal executive office as 1670 HIGHWAY 160 WEST, SUITE 205, FORT MILL, SC 29708 (SCHEDULE 13G, 2026-08-21).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-14 | Armistice Capital, LLC | 4.99% | SCHEDULE 13G/A |
| 2026-02-11 | Joseph Reda | 7.5% | SCHEDULE 13G |
| 2026-02-11 | Gregory Castaldo | 7.5% | SCHEDULE 13G |
| 2026-02-13 | Jonathan Juchno | 9.6% | SCHEDULE 13G |
| 2026-05-14 | C/M Capital Master Fund, LP | 0% | SCHEDULE 13G/A |
| 2026-07-20 | Seg Jets Spv I, LLC | 9.79% | SCHEDULE 13G |
| 2026-08-21 | C/M Capital Partners, LP | 9.99% | SCHEDULE 13G |
Questions about who owns Catheter Precision, Inc.
Who owns Catheter Precision, Inc.?
On this page, 4 holders' latest ownership filings report 5% or more of Catheter Precision, Inc.: C/M Capital Partners, LP (9.99%, Schedule 13G, filed 2026-08-21), Seg Jets Spv I, LLC (9.79%, Schedule 13G, filed 2026-07-20), Joseph Reda (7.5%, Schedule 13G, filed 2026-02-11) and Gregory Castaldo (7.5%, Schedule 13G, filed 2026-02-11).
Who are the largest shareholders of Catheter Precision, Inc.?
By the share each holder's latest filing reports, the largest holders of Catheter Precision, Inc. on this page are C/M Capital Partners, LP (9.99%), Seg Jets Spv I, LLC (9.79%) and Joseph Reda (7.5%).
When did C/M Capital Partners, LP buy into Catheter Precision, Inc.?
The filings give report dates, not purchase dates. The earliest filing from C/M Capital Partners, LP on this page is the Schedule 13G, filed 2026-08-21, reporting 9.99%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Catheter Precision, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 2, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
Tools for this story
Each opens in a new tab, filled in for Catheter Precision, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.